Reaction
Necrotising Retinitis reporting signals
As of the last recalculation, Necrotising Retinitis appears in 630 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR (PRR 141.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ganciclovir | 41 | 141.5 | 142.1 |
| Ganciclovir Sodium | 41 | 136.8 | 137.4 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 46 | 69.9 | 70.1 |
| Amphotericin B | 21 | 57.3 | 57.3 |
| Triamcinolone Acetonide | 46 | 53.0 | 53.1 |
| Posaconazole Delayed-Release | 16 | 49.4 | 49.4 |
| Valganciclovir Hydrochloride Powder, | 16 | 44.4 | 44.5 |
| Prednisolone Acetate | 13 | 42.4 | 42.4 |
| Efavirenz | 13 | 39.3 | 39.4 |
| Valganciclovir | 19 | 34.3 | 34.3 |
| Valganciclovir Hydrochloride | 19 | 34.3 | 34.3 |
| Posaconazole | 16 | 33.4 | 33.4 |
| Cefepime | 13 | 30.6 | 30.6 |
| Sirolimus | 12 | 30.0 | 30.0 |
| Voriconazole Injection | 18 | 28.2 | 28.2 |
| Mycophenilic Acid | 17 | 27.8 | 27.8 |
| Cefepime Hydrochloride | 13 | 27.2 | 27.2 |
| Tenofovir Disoproxil Fumarate Tablets | 7 | 27.1 | 27.1 |
| Nevirapine | 7 | 25.9 | 25.9 |
| Voriconazole | 20 | 22.4 | 22.4 |
| Valacyclovir | 25 | 20.6 | 20.6 |
| Lamivudine Oral | 15 | 20.0 | 20.1 |
| Lamivudine | 18 | 19.8 | 19.8 |
| Tofacitinib Citrate | 7 | 17.8 | 17.8 |
| Remdesivir | 5 | 12.5 | 12.5 |
| Faricimab | 3 | 12.3 | 12.3 |
| Obinutuzumab | 6 | 12.2 | 12.2 |
| Ruxolitinib | 25 | 12.0 | 12.0 |
| Ranibizumab | 9 | 11.3 | 11.4 |
| Tenofovir Disoproxil Fumarate | 11 | 11.2 | 11.2 |
| Aflibercept | 9 | 9.7 | 9.7 |